This document discusses methods for valuing intellectual property in healthcare technology. It outlines several valuation methods and their advantages and disadvantages, including market, cost, income/DCF, and Monte Carlo approaches. Healthcare technology valuations are challenging due to high development costs, changing revenue models, and uncertainty around markets and outcomes. The best approach may be Monte Carlo simulations that account for variability in key metrics like investment, demand, and profitability. Valuations require understanding technology, markets, and success factors for healthcare investments.